Arkolith/Insider Trading/ALDX/Form 4

Brady Todd C

President and CEO, DirectorAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4 · filed Sep 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 7, 2023Option exercise(M)192K$0.55$106K1.6M
Sep 7, 2023Tax withholding(F)74K$7.22$533K1.7M
Sep 7, 2023Option exercise(M)48K$0.55$26K1.7M
Sep 7, 2023Option exercise(M)33K$0.55$18K1.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 7, 2023Option exercise(M)48K—$00
Sep 7, 2023Option exercise(M)192K—$00
Sep 7, 2023Option exercise(M)33K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-047530) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML